Middle East and Africa Biofilms Treatment Market to Grow at a CAGR of 6.9% to reach US$ 197.81 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Biofilms Treatment Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Biofilms Treatment Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Incidence of Chronic, Surgical, and Traumatic Wounds
5.1.2 Increasing Number of Burn Injuries

5.2 Market Opportunities

5.2.1 Development of Novel Technologies

5.3 Future Trends

5.3.1 High Cost of Treating Wounds

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Biofilms Treatment Market Regional Analysis

6.1 Middle East and Africa Biofilms Treatment Market Overview

6.2 Middle East and Africa Biofilms Treatment Market Revenue 2017-2027 (US$ Million)

6.3 Middle East and Africa Biofilms Treatment Market Forecast Analysis

7. Middle East and Africa Biofilms Treatment Market Analysis – by Product

7.1 Debridement Equipment

7.1.1 Overview
7.1.2 Debridement Equipment: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Gauzes and Dressings

7.2.1 Overview
7.2.2 Gauzes and Dressings: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Grafts and Matrices

7.3.1 Overview
7.3.2 Grafts and Matrices: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Biofilms Treatment Market Analysis – by Wound

8.1 Traumatic and Surgical Wounds

8.1.1 Overview
8.1.2 Traumatic and Surgical Wounds: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Diabetic Foot Ulcers

8.2.1 Overview
8.2.2 Diabetic Foot Ulcers: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Pressure Ulcers

8.3.1 Overview
8.3.2 Pressure Ulcers: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Venous Leg Ulcers

8.4.1 Overview
8.4.2 Venous Leg Ulcers: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9. Middle East and Africa Biofilms Treatment Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Venous Leg Ulcers: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Home Care Settings

9.2.1 Overview
9.2.2 Venous Leg Ulcers: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10. Middle East and Africa Biofilms Treatment Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Biofilms Treatment Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Middle East and Africa Biofilms Treatment Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Biofilms Treatment Market Breakdown, by Product
10.1.1.1.2 South Africa: Middle East and Africa Biofilms Treatment Market Breakdown, by Wound
10.1.1.1.3 South Africa: Middle East and Africa Biofilms Treatment Market Breakdown, by End User

10.1.1.2 Saudi Arabia: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Biofilms Treatment Market Breakdown, by Product
10.1.1.2.2 Saudi Arabia: Middle East and Africa Biofilms Treatment Market Breakdown, by Wound
10.1.1.2.3 Saudi Arabia: Middle East and Africa Biofilms Treatment Market Breakdown, by End User

10.1.1.3 UAE: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Biofilms Treatment Market Breakdown, by Product
10.1.1.3.2 UAE: Middle East and Africa Biofilms Treatment Market Breakdown, by Wound
10.1.1.3.3 UAE: Middle East and Africa Biofilms Treatment Market Breakdown, by End User

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Biofilms Treatment Market Breakdown, by Product
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Biofilms Treatment Market Breakdown, by Wound
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Biofilms Treatment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Biofilms Treatment Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Smith & Nephew

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 MiMedx

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 ConvaTec Group Plc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Coloplast Group

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Mölnlycke Health Care AB.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Organogenesis Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Integra Life Sciences Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 B. Braun Melsungen AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Hartman Group

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Medline Industries, Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights